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Background: To assess arterial inflammation, using 18-F-fluorodeoxyglucose positron emission tomography/computed tomography imaging (FDG-
PET/CT), in patients with chronic kidney disease (CKD).
methods: Patients (N=322, mean age±SEM: 68.7±0.5, 58% male) undergoing FDG-PET/CT imaging for clinical indications were studied 
retrospectively: 166 patients with CKD and 166 control patients without CKD (matched by age, gender, and presence/absence of clinical 
atherosclerosis). CKD was defined per NKF guidelines with a calculated glomerular filtration rate (GFR). Arterial inflammation was assessed by 
measuring aortic FDG uptake by PET, while blinded to patient identifiers.
results: Arterial inflammation was higher in patients with CKD compared to matched controls (standardized uptake value, SUV: (2.34 ±0.04 
vs. 2.15 ±0.04; p<0.001). Group differences remained significant after correcting for background SUV (target to background ratio). SUV was also 
elevated in CKD among patients with FRS<10 (p<0.001). Arterial SUV correlated inversely with GFR after adjusting for cardiovascular risk factors, 
cancer and statin use (R=-0.2, p<0.001).
conclusions: CKD is associated with increased arterial inflammation beyond that of controls. Current risk stratification tools may underestimate 
presence of atherosclerosis in patients with CKD. Further studies are required to evaluate whether attenuation of the arterial inflammatory process 
will decrease cardiovascular events in CKD.
